Bangladesh vs Tajikistan: Expected share of deaths from non-communicable diseases
Bangladesh
18.1%
in 2021
Tajikistan
18.1%
in 2021
Bangladesh rank
99th
Tajikistan rank
99th
Expected share of deaths from non-communicable diseases over time
- Bangladesh
- Tajikistan
How they compare
Bangladesh currently reports 18.1% against 18.1% in Tajikistan, a difference of 0.0%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Tajikistan ahead.
Bangladesh ranks 99th and Tajikistan ranks 99th of 185 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Bangladesh | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.7% | 28.3% | 4.6% | Tajikistan |
| 2010s | 19.8% | 22.1% | 2.3% | Tajikistan |
| 2020s | 18.5% | 18.4% | 0.1% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected share of deaths from non-communicable diseases, Bangladesh or Tajikistan?
- Bangladesh, at 18.1% against 18.1% in Tajikistan as of 2021.
- What is the difference in expected share of deaths from non-communicable diseases between Bangladesh and Tajikistan?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Tajikistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Bangladesh and Tajikistan rank globally for expected share of deaths from non-communicable diseases?
- Bangladesh ranks 99th and Tajikistan ranks 99th of 185 countries.
- Where does this data come from?
- World Health Organization (WHO), Global Health Observatory, via World Bank (2026) – processed by Our World in Data, published as Expected share of deaths from non-communicable diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.